Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation
PHASE2
For patients with recurrent liver cancer after liver transplantation, the m...
Status
Unknown
Location
Department of Liver Transplantation, the Third Affiliated Hospital of Sun Yat-sen University
Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
PHASE2
This phase II trial studies how well giving bevacizumab, radiation therapy,...
QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy
PHASE1
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma
PHASE1
This study is designed to evaluate the efficacy and safety of sintilimab-be...
Through this study our aim was to evaluate whether significant change in se...
Status
Completed
Location
Assiut children's hospital
Start Date
2020-02-01
Trial ID
NCT04215601
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
PHASE2
Pre-clinical data and recently published clinical data suggest a synergisti...
Status
Completed
Location
University of Pennsylvania; Abramson Cancer Center; Lymphoma Program